(20s) – protopanaxadiol
Application Of Protopanaxadiol
20s) - protopanaxadiol (20 epiprotopanaxadiol) is a glycosidic ligand metabolic derivative of protopanaxadiol ginsenoside and an apoptosis inducer.
Name Of Protopanaxadiol
English Namer :(20S)-protopanaxadiol
Chinese Alias :20 (s) - protopanaxadiol | protopanaxadiol (PPD)
Biological Activity Of Protopanaxadiol
Description: (20s) - protopanaxadiol (20 epiprotopanaxadiol) is a glycosidic ligand metabolic derivative of protopanaxadiol ginsenoside and an apoptosis inducer.
Related categories: signaling pathway > > transmembrane transport > > P-glycoprotein
Natural Products > > steroids
Research Field > > cancer
References: [1] Liu GY, et al. 20S-protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways. J Nat Prod. 2007 Feb; 70(2):259-64.
[2]. Zhao Y, et al. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells. Planta Med. 2009 Aug; 75(10):1124-8.
Physicochemical Properties Of Protopanaxadiol
Density: 1.0 ± 0.1 g / cm3
Boiling Point: 559.5 ± 40.0 ° C at 760 mmHg
Molecular Formula: c30h52o3
Molecular Weight: 460.732
Flash Point: 226.1 ± 21.9 ° C
Exact Mass: 460.391632
PSA:60.69000
LogP:7.59
Steam Pressure: 0.0 ± 3.5 mmHg at 25 ° C
Refractive index: 1.529
English Alias Of Protopanaxadiol
Protopanaxadiol
Protopanaxtriol
(20S)-Protopanaxadiol
20(S)-Protopanaxdiol
(3β,12β)-Dammar-24-ene-3,12,20-triol
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., established in March 2012, is a high-tech enterprise integrating R & D, production and sales. It is mainly engaged in the production, customization and production process development of active components of natural products, traditional Chinese medicine reference materials and drug impurities. The company is located in China Pharmaceutical City, Taizhou City, Jiangsu Province, including a 5000 square meter production base and a 2000 square meter R & D base. It mainly serves major scientific research institutes, universities and decoction piece production enterprises across the country.
So far, we have developed more than 1500 kinds of natural compound reagents, and compared and calibrated more than 300 kinds of reference materials, which can fully meet the daily inspection needs of major scientific research institutes, university laboratories and decoction pieces production enterprises.
Based on the principle of good faith, the company hopes to sincerely cooperate with our customers. Our aim is to serve the modernization of traditional Chinese medicine.
Advantageous business scope of the company:
1. R & D, production and sales of chemical reference materials of traditional Chinese medicine;
2. Customized traditional Chinese medicine monomer compounds according to customer characteristics
3. Research on quality standard and process development of traditional Chinese medicine (plant) extract
4. Technology cooperation, transfer and new drug research and development.
